Association between high molecular weight apolipoprotein isoforms and lipoprotein levels in advanced chronic kidney disease and the effect of hemodialysis

Indian Journal of Nephrology

Volumn 23, Issue 1, 2013, Pages 18-23

  Gambhir, J K ^a   Kalra, O P ^a   Khaira, A ^a   Kaur, H ^a  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

Author keywords

Apo(a) isoforms; Chronic kidney disease; Lipoprotein(a); Maintenance hemodialysis

Indexed keywords

APOLIPOPROTEIN; LIPOPROTEIN;

ADULT; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENETIC POLYMORPHISM; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; MALE; WAIST HIP RATIO;

EID: 84875697885     PISSN: 09714065     EISSN: 19983662     Source Type: Journal    
DOI: 10.4103/0971-4065.107189     Document Type: Article

References (31)

1. U.S. Renal Data System. USRDS 1998 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, April 1998.
2. Ponticelli C, Barbi G, Cataluppi A, Donati C, Annoni G, Brancacci D. Lipid abnormalities in maintenance dialysis patients and renal transplant recipients. Kidney Int Suppl 1978;14:S72-8.
3. Kronenberg F, Utermann G, Dieplinger H. Lipoprotein(a) in renal disease. Am J Kidney Dis 1996;27:1-25.
4. Danesh J, Collins R, Peto R. Lipoprotein(a) and coronary heart disease. meta-analysis of prospective studies. Circulation 2000;102:1082-5.
5. Gambhir JK, Kaur H, Gambhir DS, Prabhu KM. Lipoprotein(a) as an independent risk factor for coronary artery disease in patients below 40 years of age. Indian Heart J 2000;52:411-5.
6. Hoogeveen RC, Gambhir JK, Gambhir DS, Kimball KT, Ghazzaly K, Gaubatz JW, et al. Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts. J Lipid Res 2001;42:631-8.
7. Gambhir JK, Kaur H, Prabhu KM, Morrisett JD, Gambhir DS. Association between lipoprotein(a) levels, apo(a) isoforms and family history of premature CAD in young Asian Indians. Clin Biochem 2008;41:453-8.
8. Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest 1987;80:458-65.
9. Sandholzer C, Hallman DM, Saha N, Sigurdsson G, Lackner C, Császár A, et al. Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups. Hum Genet 1991;86:607-14.
10. Rifai N, Heiss G, Doetsch K. Lipoprotein(a) at birth, in blacks and whites. Atherosclerosis 1992;92:123-9.
11. Elisaf MS, Millionis HJ, Siamopoulos KC. Increased serum lipoprotein(a) levels in patients with early renal failure. Ann Intern Med 1999;130:1028-9.
12. Kalra OP, Khaira A, Gambhir JK, Agarwal S, Bhargava SK. Lipoprotein(a) in chronic renal failure: effect of maintenance hemodialysis. Hemodial Int 2003;7:326-31.
13. Frischmann ME, Kronenberg F, Trenkwalder E, Schaefer JR, Schweer H, Dieplinger B, et al. In vivo turnover study demonstrates diminished clearance of lipoprotein(a) in hemodialysis patients. Kidney Int 2007;71:1036-43.
14. Dieplinger H, Lackner C, Kronenberg F, Sandholzer C, Lhotta K, Hoppichler F, et al. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a). J Clin Invest 1993;91:397-401.
15. Kronenberg F, Kuen E, Ritz E, Junker R, König P, Kraatz G, et al. Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure. J Am Soc Nephrol 2000;11:105-15.
16. Parsons DS, Reaveley DA, Pavitt DV, Misra M, Brown EA. Lipoprotein(a) levels in those with high molecular weight apo(a) isoforms may remain low in a significant proportion of patients with end-stage renal disease. Nephrol Dial Transplant 2003;18:1848-53.
17. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70.
18. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
19. Kronenberg F, Kronenberg MF, Kiechl S, Trenkwalder E, Santer P, Oberhollenzer F, et al. Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: Prospective results from the Bruneck study. Circulation 1999;100:1154-60.
20. Kraft HG, Köchl S, Menzel HJ, Sandholzer C, Utermann G. The apolipoprotein(a) gene: A transcribed hypervariable locus controlling plasma lipoprotein(a) concentration. Hum Genet 1992;90:220-30.
21. Lackner C, Boerwinkle E, Leffert CC, Rahmig T, Hobbs HH. Molecular basis of apolipoprotein(a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. J Clin Invest 1991;87:2153-61.
22. Rader DJ, Cain W, Ikewaki K, Talley G, Zech LA, Usher D, et al. The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate. J Clin Invest 1994;93:2758-63.
23. Kronenberg F, König P, Lhotta K, Ofner D, Sandholzer C, Margreiter R, et al. Apolipoprotein(a) phenotype-associated decrease in lipoprotein(a) plasma concentrations after renal transplantation. Arterioscler Thromb 1994;14:1399-404.
24. Vasisht S, Gulati R, Srivastava LM, Narang R, Chopra V, Srivastava N, et al. Apolipoprotein(a) polymorphism and its association with plasma lipoprotein(a) levels: A north Indian study. Indian Heart J 2000;52:165-70.
25. Gaw A, Boerwinkle E, Cohen JC, Hobbs HH. Comparative analysis of the apo(a) gene, apo(a) glycoprotein, and plasma concentrations of Lp(a) in three ethnic groups. Evidence for no common "null" allele at the apo(a) locus. J Clin Invest 1994;93:2526-34.
26. Kronenberg F, Trenkwalder E, Lingenhel A, Friedrich G, Lhotta K, Schober M, et al. Renovascular arteriovenous differences in Lp[a] plasma concentrations suggest removal of Lp[a] from the renal circulation. J Lipid Res 1997;38:1755-63.
27. Mooser V, Marcovina SM, White AL, Hobbs HH. Kringle-containing fragments of apolipoprotein(a) circulate in human plasma and are excreted into the urine. J Clin Invest 1996;98:2414-24.
28. Kostner K, Spitzauer S, Rumpold H, Maurer G, Knipping G, Hrzenjak A, et al. Urinary excretion of apolipoprotein(a): relation to other plasma proteins. Clin Chim Acta 2001;304:29-37.
29. Kuboyama M, Ageta M, Ishihara T, Fujiura Y, Kashio N, Ikushima I. Serum lipoprotein(a) concentration and Apo(a) isoform under the condition of renal dysfunction. J Atheroscler Thromb 2003;10:283-9.
30. Milionis HJ, Elisaf MS, Tselepis A, Bairaktari E, Karabina SA, Siamopoulos KC. Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure. Am J Kidney Dis 1999;33:1100-6.
31. Gazzaruso C, Bonetti G, Garzaniti A, Pini G, Ragazzoni A, Bianchi C, et al. Increased plasma concentrations of lipoprotein(a) for every phenotype of apolipoprotein(a) in patients with chronic renal failure treated by hemodialysis. Nutr Metab Cardiovasc Dis 1996;6:203-10.